Cargando…

Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ injury. Renal or cardiac involvement is most common, though any organ outside the central nervous system can develop amyloid d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Christopher E., Byku, Mirnela, Hladik, Gerald A., Jain, Koyal, Traub, Rebecca E., Tuchman, Sascha A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259942/ https://www.ncbi.nlm.nih.gov/pubmed/35814419 http://dx.doi.org/10.3389/fonc.2022.907584

Ejemplares similares

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
por: Kaufman, Gregory P., et al.
Publicado: (2021)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
por: Morisaki, Shinsuke, et al.
Publicado: (2021)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2018)

Neuromodulation of the Failing Heart: Lost in Translation?
por: Byku, Mirnela, et al.
Publicado: (2016)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021
por: Hasib Sidiqi, M., et al.
Publicado: (2021)

Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report
por: Doshi, Krishna, et al.
Publicado: (2022)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)

Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
por: Hwa, Yi L., et al.
Publicado: (2019)

Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
por: Swaminathan, Renugadevi, et al.
Publicado: (2021)

Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
por: Ozercan, Mubin, et al.
Publicado: (2021)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis
por: Bhutani, Divaya, et al.
Publicado: (2023)

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
por: Swuec, Paolo, et al.
Publicado: (2019)

Real world data on light chain cardiac amyloidosis: Still a delayed diagnosis
por: Chatzileontiadou, Sofia, et al.
Publicado: (2022)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
por: Miao, Fujia, et al.
Publicado: (2023)

Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)

Simultaneous Clinical Presentation of Renal Cell Carcinoma and Immunoglobulin Light Chain Amyloidosis
por: Prasad, Bhanu, et al.
Publicado: (2018)

Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications
por: Xu, Linchun, et al.
Publicado: (2021)

Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder
por: Martínez, José C., et al.
Publicado: (2022)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

LVAD therapy as a catalyst to heart failure remission and myocardial recovery
por: Hamad, Eman A., et al.
Publicado: (2023)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Racial disparities in patients diagnosed with light chain (AL) amyloidosis
por: D’Souza, Anita, et al.
Publicado: (2021)

Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease
por: Cooper, Shawna A., et al.
Publicado: (2022)

Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency
por: Guo, Yong-mei, et al.
Publicado: (2019)

Amyloid cranial polyneuropathy: A rare neurological presentation of immunoglobulin light‐chain amyloidosis
por: Agarwal, Abhinav, et al.
Publicado: (2021)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
por: Vergaro, Giuseppe, et al.
Publicado: (2021)

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
por: Fraser, Cameron S., et al.
Publicado: (2022)

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
por: Wechalekar, A D, et al.
Publicado: (2017)

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
por: Morgan, Gareth J., et al.
Publicado: (2021)

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
por: Warsame, R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_97v7vivdokaedb9rurliljol5m